
SS-31
SS-31 (Elamipretide, MTP-131)
SS-31, also known as elamipretide, is a synthetic tetrapeptide from the Szeto-Schiller (SS) family developed by Hazel Szeto and Peter Schiller. Its alternating aromatic and positively charged residues give it a +3 net charge at physiological pH, which lets it pass through cell membranes and concentrate several-hundred-fold at the inner mitochondrial membrane, independent of membrane potential.
In the laboratory, SS-31 is used to study mitochondrial bioenergetics and oxidative stress. A 2014 British Journal of Pharmacology review by Szeto summarizes work showing that it binds cardiolipin, a phospholipid unique to the inner mitochondrial membrane, and helps preserve the structure of the cristae where the electron transport chain operates. It has been studied in models of ischemia-reperfusion, heart failure, neurodegeneration and age-related mitochondrial decline.
PhysIQ Peptides supplies SS-31 as a lyophilized powder, third-party tested for purity and identity, for in vitro and laboratory research use only.
Select size
Choose how to buy
You save $2.25 every reship · ≈ $27.38 saved per year
Auto-delivered • Skip or cancel anytime • Never run out
Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.
- Purity
- 99%
- Form
- Powder (lyophilized)
- CAS Number
- 736992-21-5
- Molecular Formula
- C32H49N9O5
- Molecular Weight
- 639.8 g/mol
- Available sizes
- 10mg, 50mg
Sequence
D-Arg-Dmt-Lys-Phe-NH2 (Dmt = 2,6-dimethyltyrosine)
Mechanism of Action
SS-31 selectively binds cardiolipin on the inner mitochondrial membrane. This interaction is reported to stabilize cristae structure, protect cytochrome c's electron-carrying function, improve electron transport chain efficiency and reduce mitochondrial reactive oxygen species production in cell and animal models. Its dimethyltyrosine residue may also contribute direct antioxidant activity.
Research Areas
- ●Cardiolipin and inner mitochondrial membrane biology
- ●Mitochondrial bioenergetics and ROS
- ●Ischemia-reperfusion models
- ●Age-related mitochondrial dysfunction
Selected References
- Szeto HH. Br J Pharmacol. 2014;171(8):2029-2050.




